FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/08/044906 [Registered on: 25/08/2022] Trial Registered Prospectively
Last Modified On: 24/08/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Unani
Screening 
Study Design  Single Arm Study 
Public Title of Study   Effect of Unani formulation in Tinea Corporis 
Scientific Title of Study   Efficacy of Nuqoo e Mundi(Sphaeranthus indicus) and Roghan e Neem(Azadirachta indica) in Quba [Tinea corporis] 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sayema Khan 
Designation  PG Scholar 
Affiliation  Government Unani Medical College and Hospital 
Address  Siddaiah puranik road Basaveshwar nagar bangalore
Siddaiah puranik road Basaveshwar nagar bangalore
Bangalore
KARNATAKA
560079
India 
Phone  7289805073  
Fax    
Email  sayemakhan91@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr mohammed Asif siddiqi 
Designation  Associate Professor 
Affiliation  Government Unani Medical College and Hospital 
Address  Siddaiah puranik road Basaveshwar nagar bangalore
Siddaiah puranik road Basaveshwar nagar bangalore
Bangalore
KARNATAKA
560079
India 
Phone  9986812499  
Fax    
Email  drasif.i.siddiqui@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sayema Khan 
Designation  PG Scholar 
Affiliation  Government Unani Medical College and Hospital 
Address  Siddaiah puranik road Basaveshwar nagar bangalore
Siddaiah puranik road Basaveshwar nagar bangalore
Bangalore
KARNATAKA
560079
India 
Phone  9986812499  
Fax    
Email  sayemakhan91@gmail.com  
 
Source of Monetary or Material Support  
Room no 8 Government Unani Medical College and Hospital karnataka Bengaluru  
 
Primary Sponsor  
Name  Government unani medical college and hospital Bengaluru Karnataka 
Address  Dr siddaiah puranik road basaveshwar nagar bengaluru karnataka 560079  
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sayema khan  Government Unani Medical College and Hospital  Department of Amraz e Jild Wa Tazeeniyat 80 feet ring road stage 1 KHB colony basaveshwar nagar bangalore
Bangalore
KARNATAKA 
7289805073

sayemakhan91@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee for Biomedical Research   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: L088||Other specified local infections of the skin and subcutaneous tissue,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Mundi and Neem  Nuqoo e Mundi 7gm in 30 ml of water in the morning empty stomach orally for 28 days Roghan-e-Neem For local application over the lesion twice a day for 28 days  
Comparator Agent  Not applicable   not applicable 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients age between 18-60 years of all gender
Mycological(KOH) confirmed cases of tinea corporis (KOH +ve cases)
Patients with 2 years of chronicity of tinea corporis
Patients who are willing to sign the consent form for the trial
 
 
ExclusionCriteria 
Details  Age group less than 18 years or more than 60 years
Patients with DM HTN renal and hepatic impairement hypersensitivity to drug
Patients with severe skin infections
Pregnant and lactating mothers
Cases other than tinea corporis
Patient on corticosteroid treatment
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
KOH examination of skin scrap should be negative  28 days 
 
Secondary Outcome  
Outcome  TimePoints 
Reduction in subjective parameters will be according to arbitrary grading scale or physicians global assesment score  0th 7th 14th 21st 28th 35th day 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   01/09/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Not yet published 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Clinically diagnosed cases of tinea corporis fulfilling the inclusion criteria after obtaining written consent will be enrolled in the intervention of Nuqoo-e-Mundi(orally) 7 gms with 30 ml of water and local application of Roghan-e- Neem (twice a day) for a duration of 28 days with follow up assessment on every 7th day (7th 14th  21st  28th 35th day). The pre and post treatment objective findings(effects) will be assessed.

 
Close